Purpose: Electroencephalogram (EEG) alpha asymmetry (AA) in depressive disorders has been of interest over the last few decades, but it continues to remain unclear whether EEG AA can discriminate between healthy and depressive individuals. Materials and methods: A systematic literature search for papers addressing EEG AA using the keywords alpha asymmetry, depression, and EEG was performed in PubMed. All studies were checked for sample size, gender, handedness, reference, recording protocol, EEG band range, impedance, type of analysis, drugs, and comorbidity. Results: A total of 61 articles were found, of which 44 met our inclusion criteria. They have been consecutively analyzed in respect of methodology and results. Approximately 25% (11/44) of the studies did not mention or ignored handedness, 41% (18/44) of the studies used data with only self-reported handedness, and only 34.1% (15/44) of all studies tested handedness. Only 35% (15/44) of the studies reported pharmacological treatment, and only 35% (15/44) of the studies controlled for medication. A total of 52% (23/44) of the studies reported comorbidity, and only 30% (13/44) of the studies controlled for comorbidity. Only 29.6% (13/44) of the studies reported education. In all, 30.5% (13/44) of the studies analyzed group differences and correlations, while 15.9 (7/44) of the studies used only correlational analyses. A total of 52.3% (23/44) of the studies analyzed only group differences. Alpha range was fixed (8-13 Hz) in 59.1% (26/44) of all studies. Reference to common average was used in seven of 44 studies (15.9%). In all, nine of 44 (20.5%) studies used the midline central position as reference, 22 of 44 (50%) studies used the ear or the mastoid as reference, and four of 44 (9.1%) studies used the nose as reference. Conclusion: Discriminative power of EEG AA for depressed and healthy controls remains unclear. A systematic analysis of 44 studies revealed that differences in methodology and disregarding proper sampling are problematic. Ignoring handedness, gender, age, medication, and comorbidity could explain inconsistent findings. Hence, we formulated a guideline for requirements for future studies on EEG AA in order to allow for better comparisons.
Introduction
Over the last few decades, a lot of research concerning electroencephalogram (EEG) alpha asymmetry (AA) in depressive disorders (DD) has been conducted. EEG is of interest in respect of diagnosis of DD, with a special focus on frontal EEG AA, 1,2 as it is believed to be a useful biomarker for depression. [1] [2] [3] EEG AA is usually calculated by subtracting the right-side EEG power estimates from the respective counterpart on the other side. While normal controls have more right-sided frontal alpha power, depressive patients seem to have comparatively higher left frontal alpha power. 1, 2, 4 Cortical activity is related to reduced EEG power, which is reflected in left frontal hypoactivation in On the other hand, higher alpha power could be interpreted as correlate of active inhibition rather than cognitive idleness. [6] [7] [8] Several meta-analyses attempted to shed light on the usefulness of EEG AA for diagnostic purposes. 9 ,10 While Gold et al 8 concluded that there is sufficient reliability of frontal AA, correlations with depression scales were small and nonsignificant. The most recent meta-analysis including 883 major depressed patients and 2,161 controls found only a nonsignificant effect size for EEG AA in respect of major DD. 10 Gender, age, and severity of depression were especially identified as covariates of EEG AA. 10 While many studies focus on depressive symptoms, there are, however, several subtypes of DD in terms of symptoms, duration, and etiology. In clinical routine, DD are diagnosed by a physician using ICD-10, 11 Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV), 12 or Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-V) 13 criteria. Depression scales are common for further specification of symptomatology and as diagnostic tools.
Another issue worth considering is the fact that most studies include only young patients, 14 and studies including older individuals were not able to replicate the diagnostic validity of EEG AA. [15] [16] [17] One major problem in this context might be publication bias, which makes it hard to publish negative results on EEG AA and leads to overinterpretation of results. Another interesting aspect is the fact that most studies deal with female individuals and not with males. Since frontal AA was found to be more consistent in women, 18 many studies focus only on females.
While age and gender data are easily obtained, handedness needs specific testing. Simple verbal information about the presumed handedness does not give valid information about hemispheric lateralization. The Edinburgh Handedness Inventory 19 can be used for proper documentation. Jesulola et al 20 did not report handedness and argued that hemispheric brain dominance is not only determined by handedness. Approximately 61%-70% of left-handed people have left hemispheric dominance. 21, 22 As mentioned before, age seems to be a covariate of EEG AA, which raises the question if cognition is also a covariate. Cognition of participants is mostly ignored, although evidence for alpha 1 power correlation with cognitive abilities was found. 23 Alpha power and theta power are correlated with memory decline 24, 25 and cognitive decline. 26 Aging must be considered in respect of EEG AA, as there are specific age-related changes that could explain why EEG AA changes are not found in geriatric patients. 16 One important theory, the right hemi-aging hypothesis, proposes that the right hemisphere is more affected by agerelated changes. 27 This kind of hemispheric difference could also affect AA. Cabeza 28 established the "hemispheric asymmetry reduction in old adults" model, which assumes that hemispheric asymmetry is reduced during cognitive performance and reflects compensatory mechanisms. A third theory named "compensation-related utilisation of neural circuits hypothesis" states that elderly individuals activate additional brain regions not only from the contralateral hemisphere. 29 Closely related to cognitive ability is education, which could be easily ascertained and might as well affect EEG measures. Furthermore, educational biases between groups need to be ruled out in addition to gender, age, and cognition. Even sexual motivation seems to affect frontal AA, 30 expressed in a positive relationship between self-reported mental sexual arousal and a more left-sided AA. While most studies report findings on EEG AA, it is hard to find a consensus on what the alpha band range is. Some studies use fixed ranges, while others use individual alpha bands. 31 Evidence for age-related individual alpha frequency changes can be found, and also for smaller amplitudes in older adults. 32 Controlling for drugs is another important possible confounder in studies on EEG AA. While many studies 15, 16, 85 describe medication taken by the probands, any effects on the recorded EEG are simply ignored.
Summarizing the findings on EEG AA, it becomes evident that diagnostic validity is limited. One reason for this limitation could be the poor quality of some studies on EEG AA; also sample selection seems to affect the outcome. The aim of this review was to sum up methods used in studies on EEG AA and discuss potential flaws, which devalue the outcome and cannot help to shed light on the diagnostic validity of EEG AA. Not only handedness, gender, age, and education ought to be addressed but also culture, medication, and cognition need to be considered. A list of minimal requirements needs to be created in order to improve the quality of future studies on EEG AA and make the results comparable.
Materials and methods
Search procedure and characteristics of identified studies On 13 July 2017, a search of PubMed was conducted using the combination of the following keywords in title and abstract: alpha asymmetry, depression, and EEG. Overall, the search resulted in finding 61 articles. Only studies that determined asymmetry on the basis of EEG data were included. Inclusion criteria for this review were a focus on EEG AA and affective disorders. Studies whose research focus was 
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eeG alpha asymmetry in depressive disorder patients: current perspectives on the analysis of other EEG correlates instead of AA and/or other mental disorders or main symptoms that did not include depression symptoms were excluded. No study was excluded due to methodological limitations, but rather because it missed the proposed research topic. In the next step, cultural background, type of study, sample size, percentage of righthanders, and number of female participants were collected. Furthermore, we collected data on education, reference style, recording protocol and length, as well as impedance and alpha band range. Moreover, "controlling for handedness" and "controlling for drugs" were added. All collected data were transferred to Microsoft Excel 2016. Descriptive data analysis was performed using IBM SPSS Statistics 24.
Results
A total number of 61 publications were found using the following search criteria in PubMed (https://www.ncbi.nlm. In all, 17 studies were excluded from further analysis since they did not fully meet search criteria. [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] From the remaining 44 studies published between 1996 and 2017, we collected data on the methods used.
Topical heterogeneity of included literature
While all studies included in this study addressed EEG AA in DD, most of the studies tried to test the validity of EEG AA as a surrogate marker for depression and claimed to show evidence for that. 4, [50] [51] [52] [53] [54] [55] [56] Some of the studies addressed specific topics such as melancholia and EEG AA. 57 It is inferred that it remains unclear whether this can be used as a surrogate marker or not. 8, 10, 20, 58 Anxiety was found to be correlated with the most evident relative change in frontal alpha asymmetry in one study. 54 Some studies only proved EEG AA findings for anxiety and not for depression. 59 EEG AA changes were found only in schizophrenia and depression and not in other clinical disorders. 60 In addition, a general decrease in EEG power in all frequency bands in depression 61 as well as a lowered frontal EEG power in rumination was found. 62 Shyness was also a criterion and was able to predict greater relative right frontal AA only after controlling for depressive mood 63 and self-esteem, which was found to be a mediator of EEG AA only in its explicit type. 64 In suicide attempters, greater alpha power over the left hemisphere was found. 65 One study addressed activity level in general, which might be correlated to EEG AA. 66 Some interventional studies also proved a shift in EEG AA. 35, [67] [68] [69] A prediction of the course of depression was not possible with EEG AA. 70 There was also a focus on whether EEG AA is a state or trait marker for depression, 16, 71, 72 which still remains undetermined. 72 A large number of the studies were not able to prove the diagnostic reliability of EEG AA. [73] [74] [75] In particular, findings on correlations between depression scores and EEG AA were inconsistent. 8, 79 Studies that addressed age had difficulties in validating previous findings on EEG AA. 16, 17, 80 Especially in young people and the oldest olds, previous EEG AA findings were not able to be replicated. 16, 17 Other factors such as cortical thickness as a mediator of AA could be ruled out. 81 Cognition was discussed as a possible moderator of EEG AA. [15] [16] [17] 82, 83 Hereditary effects might play a role, 84 but it was found that less left frontal activity at lateral sites was only associated with lifetime major depressive disorder (MDD) in offspring and not in parental MDD. 47 The issue of drug effects on EEG AA was discussed. 85 It was also argued that conventional EEG analysis lacks temporal and spatial precision. 56 
Methodological analysis
In Table 1 , a comparison of methods in all publications is provided. While most studies tried to focus on EEG AA correlates of depression, the samples were small and, in many cases, not representative. Using students as probands is common as is the use of nonclinical samples. A transfer of the evidence data to clinical patients is often not possible since no clinical samples were used for analysis. Most of the studies used only female participants. The classification of depressive status was measured using depression scores or symptom ratings according to ICD-10 and DSM-IV. Recording length varied between 2 and 8 minutes. The reference points for EEG measurement were placed on the ear, mastoid, nose, or the midline central position (Cz) in most of the studies. In detail, reference to common average (CA) was used in seven of 44 studies (15.9%), while nine of 44 (20.5%) studies used Cz as reference. Half of all studies (22/44) used the ear or the mastoid as reference, and four of 44 (9.1%) studies used the nose as reference.
Re-referencing was also common in some cases. Statistical analysis relied on correlational analysis and analyses of variance (ANOVAs) in most of the studies. Analysis of group differences and correlation was performed in 30 .5% of studies, correlational analysis was performed only in 15 .9% of studies, and group differences were performed in 52.3% of studies. The alpha band range was mostly fixed at 8-13 Hz (26/44 studies). Concerning the controlling for common known confounders ( (Table 2) .
Discussion
We conducted a systematic review on EEG AA in patients with DD, which is still discussed as a possible biomarker for depression. [1] [2] [3] However, the use of EEG AA as a surrogate marker for depression still remains unclear, 9,10 which is not surprising if we take a closer look on the methodological quality of studies concerning EEG AA. The issues of small sample sizes and quality have been discussed repeatedly. [8] [9] [10] In our analysis, we found that many studies on EEG AA do not consider common known confounders, which could have a tremendous effect on the recorded EEG data.
Taking a closer look at meta-analyses, 9, 10 we found that most of the analyzed studies differ in sample age, education, gender, handedness, medication, clinical symptoms and severity, and comorbidity. EEG AA was tested as a biomarker for melancholia, 57 with unclear validity. 8, 10, 20, 58 EEG AA seems to be the most robust in anxiety. 54, 59 In depression, a general decrease in EEG power can be found, 61 which is a sign of cortical activity. This can also be found in rumination. 62 Interventional studies have also been analyzed, which could prove a shift in EEG AA. 35, [67] [68] [69] Future studies on EEG AA need to focus on specific changes in the course of depression, which could also help answer the question if EEG AA is a state or trait marker for depression, which still remains unclear. 72 If EEG AA is used as a diagnostic measure for clinical depression, we will need normative data. A simple lateralization measure of activity or idleness in the brain cannot be used across different genders, age, educational levels, left-and right-handedness, and medicated and not medicated individuals. In comparison to common correlational analysis and group comparison with ANOVAs, modern statistical analysis methods, such as periburst metrics, could help overcome the lack of temporal and spatial precision. 56 A consensus of proper sampling and controlling for confounders has to be found in order to validate or reject the hypothesis of EEG as a surrogate marker or marker for treatment response. The following section lists the minimal requirements for studies on EEG AA. 
Conclusion
We conducted a literature search on EEG AA in DD and found that methodological flaws could account for the unclear results. Some of the studies do not take into consideration commonly known confounders such as education, age, gender, handedness, drugs, and comorbidity. We have designed a list of requirements to improve the quality of future studies on EEG AA, thus allowing a better comparison of results.
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